MARATTO

preprint · Research Square

Phenotypic and molecular characterization of methicillin-resistant Staphylococcus aureus (MRSA) circulating into environments in Ouagadougou, Burkina Faso.

2024Open accessUniversity of Douala

Abstract

<title>Abstract</title> Meticillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) diagnostic techniques are not very easy in rattan practices in Burkina Faso and West African. This is main difficulty of good MRSA surveillance in this region. Thus, to consolidate MRSA data in locality that, 33 strains of <italic>S. aureus</italic> were tested for susceptibility to cefoxitin according using standard method. In addition, the genetic determinants including <italic>mecA</italic> gene and <italic>SCCmec</italic> cassettes were searched using conventional PCR technic to same strains. These protocols made it possible to obtain prevalence’s of 42.42% (14/33) and 18.18% (6/33) respectively of <italic>S. aureus</italic> resistant to cefoxitin and positive in Chrom MRSA ID® agar medium. From 33 <italic>S. aureus</italic> studied, 6 strains (18.18%) and 7 strains (21.21%) all of human origin were respectively positive for <italic>mecA</italic> resistance gene and <italic>SCCmec</italic> IVa cassette. This study brought circulating MRSA in the city of Ouagadougou. These MRSA harbor <italic>mecA</italic> resistance genes and <italic>SCCmec</italic> IVa cassettes.

Research topics

  • Antimicrobial Resistance in Staphylococcus
  • Bacterial biofilms and quorum sensing
  • Biochemical and Structural Characterization

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21203/rs.3.rs-4405385/v1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.